370 related articles for article (PubMed ID: 37240378)
1. The Many Ways to Deal with STING.
Coderch C; Arranz-Herrero J; Nistal-Villan E; de Pascual-Teresa B; Rius-Rocabert S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240378
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of porcine STING
Cong X; Yuan Z; Du Y; Wu B; Lu D; Wu X; Zhang Y; Li F; Wei B; Li J; Wu J; Xu S; Wang J; Qi J; Shang G; Gu L
J Biol Chem; 2019 Jul; 294(30):11420-11432. PubMed ID: 31167783
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
Xie X; Liu J; Wang X
Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
[TBL] [Abstract][Full Text] [Related]
4. Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.
Yanase Y; Tsuji G; Nakamura M; Shibata N; Demizu Y
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743289
[TBL] [Abstract][Full Text] [Related]
5. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.
Walker MM; Crute BW; Cambier JC; Getahun A
J Immunol; 2018 Nov; 201(9):2641-2653. PubMed ID: 30282750
[TBL] [Abstract][Full Text] [Related]
6. Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein.
Smola M; Gutten O; Dejmek M; Kožíšek M; Evangelidis T; Tehrani ZA; Novotná B; Nencka R; Birkuš G; Rulíšek L; Boura E
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10172-10178. PubMed ID: 33616279
[TBL] [Abstract][Full Text] [Related]
7. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
[TBL] [Abstract][Full Text] [Related]
8. Protein-Ligand Interactions in the STING Binding Site Probed by Rationally Designed Single-Point Mutations: Experiment and Theory.
Vavřina Z; Gutten O; Smola M; Zavřel M; Aliakbar Tehrani Z; Charvát V; Kožíšek M; Boura E; Birkuš G; Rulíšek L
Biochemistry; 2021 Mar; 60(8):607-620. PubMed ID: 33586948
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
10. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
[TBL] [Abstract][Full Text] [Related]
11. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
[TBL] [Abstract][Full Text] [Related]
14. Detection of Cyclic Dinucleotides by STING.
Du XX; Su XD
Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
[TBL] [Abstract][Full Text] [Related]
16. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides.
Smola M; Birkus G; Boura E
Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926
[TBL] [Abstract][Full Text] [Related]
17. The role of cGAS-STING signalling in liver diseases.
Chen R; Du J; Zhu H; Ling Q
JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
[TBL] [Abstract][Full Text] [Related]
18. Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions.
Che X; Zhang J; Zhu Y; Yang L; Quan H; Gao YQ
J Phys Chem B; 2016 Mar; 120(10):2670-80. PubMed ID: 26878265
[TBL] [Abstract][Full Text] [Related]
19. Replacement of oxygen with sulfur on the furanose ring of cyclic dinucleotides enhances the immunostimulatory effect
Saito-Tarashima N; Kinoshita M; Igata Y; Kashiwabara Y; Minakawa N
RSC Med Chem; 2021 Sep; 12(9):1519-1524. PubMed ID: 34671735
[TBL] [Abstract][Full Text] [Related]
20. The Golgi-resident protein ACBD3 concentrates STING at ER-Golgi contact sites to drive export from the ER.
Motani K; Saito-Tarashima N; Nishino K; Yamauchi S; Minakawa N; Kosako H
Cell Rep; 2022 Dec; 41(12):111868. PubMed ID: 36543137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
